Skip to content
After weeks of tension, the Supreme Court decided mifepristone can stay… for now. On the evening of April 21, the Supreme Court ruled the […]
Supreme Court says mifepristone can stay – for now Read More »
With an upsurge in sexually transmitted infections (STIs) as well as the threat of antimicrobial resistance (AMR), the U.S. must take essential action to
U.S. surge in STIs threatens to converge with antimicrobial resistance Read More »
The American Association for Cancer Research (AACR) hosted its 114th annual meeting in Florida in April. Scientists, medical professionals, and many others came together
5 new discoveries at the American Association for Cancer Research annual meeting Read More »
Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR).
We’re losing the fight against superbugs. The time to act is now. Read More »
The U.N. declared the theme of Earth Day 2023 “Invest in Our Planet.” Given the rapid increase in climate-related investments, perhaps that slogan should
Earth Day 2023: Invest in our planet Read More »
With the Texas ruling against the product mifepristone on April 7, the biotech industry came together to both denounce the ruling and help the
The week in mifepristone and understanding the deeper impacts Read More »
Concerns over sepsis, a life-threatening reaction to infections, are on the rise. And growing antimicrobial resistance (AMR) is making the condition harder to treat.
Why pediatric sepsis is on the rise – and what we can do about it Read More »
On Friday, April 14, the Biotechnology Innovation Organization (BIO) weighed in on initial guidance regarding the Drug Price Negotiation Program (Negotiation Program) under the
BIO submits comments on IRA’s Medicare Drug Price Negotiation Program Read More »
On April 18, the House Energy and Commerce Innovation, Data, and Commerce Subcommittee held a hearing on the Federal Trade Commission’s (FTC) budget for
House Energy & Commerce subcommittee spotlights ‘unfair’ PBM practices Read More »
The Inflation Reduction Act was meant to be a step forward in improving the affordability and access to innovative medical treatments, but several provisions
Podcast: The impact of the Inflation Reduction Act and EU pharma package on innovation Read More »
